In a regulatory filing, Teladoc Health reported that on September 27, Michael Waters, Chief Operating Officer of the company, resigned with good reason under his executive employment agreement with the company in connection with a change in the company’s executive reporting structure. “Mr. Waters’ resignation is effective on the close of business on December 31, 2024. The Company thanks Mr. Waters for his service,” the filing stated.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc call volume above normal and directionally bullish
- Teladoc rises 10.2%
- Teladoc rises 10.3%
- Jefferies ups Teladoc price target to $10, sees short-term opportunity in shares
- Teladoc Health Names Joseph Catapano as New SVP and CAO